Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is not known to directly cause yeast infections, and vaginal or oral thrush does not appear in the medicine's list of common side effects. That said, the relationship between tirzepatide and infection risk is worth understanding properly, because the picture has a few moving parts. Mounjaro is a prescription-only medicine that requires clinical assessment before it can be dispensed — a prescriber reviews your full health history, including anything that might make certain side effects more likely for you personally. For a clear overview of the treatment itself, the tirzepatide patient guide on this site covers the basics.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starting point for any question like this is the medicine's licensed safety profile. The Mounjaro SmPC and the NHS tirzepatide patient information page list the side effects seen across the SURMOUNT clinical programme, which enrolled thousands of adults over trials lasting up to 72 weeks. Yeast infections (vaginal candidiasis, oral thrush) are not among the common side effects (those affecting more than 1 in 100 people). Nor are they listed as uncommon ones. The side-effect profile is dominated by gastrointestinal symptoms: nausea, loose stools, constipation, burping and reflux, typically most noticeable in the first weeks after starting or after a dose increase.
That absence from the list matters. It means yeast infections were not appearing at a statistically meaningful rate in large, well-monitored trials. If you are experiencing thrush while on Mounjaro, the medicine is unlikely to be the direct cause, but that does not mean the question is pointless. Context matters a lot here.
For a broader look at how the treatment works and what the trial data actually showed, the Mounjaro overview pulls together the key facts in one place.
Here is where things get more nuanced, and this is probably the answer you were actually looking for. Mounjaro is licensed for weight management and for type 2 diabetes. In people with diabetes, elevated blood glucose is a well-established driver of recurrent yeast infections, Candida thrives in a sugary environment. Mounjaro reduces blood sugar, which over time should make thrush less likely in that group. But there is a transition period at the start of treatment, and blood-glucose fluctuations during titration may temporarily affect conditions that favour yeast growth.
Separately, because tirzepatide slows gastric emptying and changes how quickly food moves through the gut, some people notice shifts in their digestive health. The gut microbiome is sensitive to those changes. There is no established clinical evidence linking this specifically to vaginal or oral yeast infections, but it is a mechanism some patients and clinicians have pointed to anecdotally. If you are also on antibiotics at the same time (for any reason) that is a far more direct trigger for thrush than Mounjaro itself.
Questions about urinary and bladder symptoms sometimes come up alongside yeast infection queries; the page on Mounjaro and bladder infections covers that related area in detail.
If you are on Mounjaro and develop a yeast infection, the practical approach is straightforward. A single episode of thrush is common in the general population and usually responds to over-the-counter antifungal treatment. You do not need to stop your Mounjaro pen or wait for a GP appointment before treating it.
What does warrant a prescriber conversation is recurrence, three or more episodes in a year, or infections that are not clearing with standard treatment. Recurrent thrush can signal an underlying glucose issue, an immune consideration, or a drug interaction that needs a clinical eye. This is exactly the kind of detail a prescriber at a registered pharmacy reviews before and during treatment. Our clinical team looks at the full picture at every stage, not just the initial consultation.
For completeness, if you are also noticing urinary symptoms alongside any genital irritation, the pages on Mounjaro and water infections and urine infections on tirzepatide cover those separately. There is also a dedicated page on whether tirzepatide causes yeast infections that approaches the same topic from the drug-name angle, if that is the phrasing your doctor used.
One thing patients tell us they wish they had known earlier: keeping a brief note of when symptoms appear relative to your injection day can give a prescriber genuinely useful information, far more than a general description of "I keep getting infections." It is a small habit that pays off.
If you are weighing up what treatment costs across providers, the Mounjaro cost guide sets out how private pricing works in the UK, including what is and is not typically included in a quoted price. For anyone thinking about starting treatment, speaking to our prescribers is the first step, the consultation is free, and a named clinician reviews every case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.